McArdle Disease Clinical Trial
Official title:
A Phase 1b, Open-label Study to Evaluate the Safety and Tolerability of 12 Weeks Treatment With Oral REN001 in Patients With McArdle Disease (Glycogen Storage Disorder 5)
The purpose of this study is to assess REN001 safety in subjects with McArdle Disease
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03945370 -
Oral Ketone Body Supplementation in Patients With McArdle Disease
|
N/A | |
Completed |
NCT04349566 -
Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases
|
||
Enrolling by invitation |
NCT03211923 -
Muscle Relaxation in Myopathies With Positive Muscle Phenomena
|
||
Completed |
NCT03112889 -
Sodium Valproate for GSDV
|
Phase 2 | |
Completed |
NCT04694547 -
Ketogenic Diet Survey in Patients With McArdle Disease (GSDV)
|
||
Completed |
NCT03843606 -
Modified Ketogenic Diet in Patients With McArdle Disease Part A
|
N/A | |
Recruiting |
NCT04929002 -
Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases
|
||
Completed |
NCT04044508 -
Modified Ketogenic Diet in Patients With McArdle Disease Part B
|
N/A | |
Recruiting |
NCT05943678 -
Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.
|